Entries in U.S. Food and Drug Administration (2)


FDA Approves New Drug to Treat Advanced Prostate Cancer

Comstock/Thinkstock(NEW YORK) -- The U.S. Food and Drug Administration Friday approved a new drug to treat advanced prostate cancer that isn't responding to other therapies, Health Day reports.

The drug, enzalutamide, which will be sold under the brand name Xtandi, interferes with production of testosterone, which encourages prostate tumors to grow. The FDA said it is intended for men who are experiencing a recurrence or spread of prostate cancer in spite of hormone therapy or chemotherapy. The drug was approved under the agency's priority review program for drugs that may be capable of significantly advancing current treatment, according to Health Day.

Xtandi will be marketed by Astellas Pharma U.S. Inc. of Northbrook, Ill. and Medivation Inc. of San Francisco.

Copyright 2012 ABC News Radio


Device Could 'Revolutionize' Care for Heart Failure Patients

Photo Courtesy - Getty Images(COLUMBUS, Ohio) - A new device could help improve the quality of life for heart failure patients, reports HealthDay News.

The device, which monitors fluid build-up in the lungs, is implanted in the pulmonary artery in the lung and can wirelessly alert doctors if problems occur. The device could help keep heart failure patients out of the hospital by allowing a doctor to adjust a patient's medication.

"This promises to revolutionize the way we manage patients who have moderate or severe heart failure," said study author Dr. William T. Abraham, director of the division of cardiovascular medicine at Ohio State University Medical Center. "Prior to this, the tools that we could use to evaluate how heart failure patients were doing were not very revealing and so we have failed to keep patients out of the hospital."

The device, which is currently undergoing an approval process by the U.S. Food and Drug Administration, is expected to cost about $15,000.

Copyright 2011 ABC News Radio

ABC News Radio